Serum Endocan Level and Its Correlation with Clinicopathologic Features in Patients with Papillary Thyroid Cancer

• Musa Kürşad ŞENER ,
• Melia KARAKÖSE,
• Muhammet KOCABAŞ ,
• Taha Ulutan KARS ,
• Cihad SOLAK,
• Fethi YÖNET,
• Mehmet Emin GEREK,
• Fatma Hümeyra YERLİKAYA,
• Mustafa KULAKSIZOĞLU,
• Feridun KARAKURT

Affiliations

Musa Kürşad ŞENER

Clinic of Internal Medicine, Cihanbeyli State Hospital, Konya, TURKEY

Melia KARAKÖSE

Division of Endocrinology and Metabolism, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY

Muhammet KOCABAŞ

Division of Endocrinology and Metabolism, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY

Taha Ulutan KARS

Division of Hematology, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY

Cihad SOLAK

Clinic of Internal Medicine, Konya Numune State Hospital, Konya, TURKEY

Fethi YÖNET

Division of Nephrology, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY

Mehmet Emin GEREK

Clinic of Internal Medicine, Konya Numune State Hospital, Konya, TURKEY

Fatma Hümeyra YERLİKAYA

Department of Biochemistry, Selçuk University Faculty of Medicine, Konya, TURKEY

Mustafa KULAKSIZOĞLU

Division of Endocrinology and Metabolism, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY

Feridun KARAKURT

Division of Endocrinology and Metabolism, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY